Serum neurofilament light chain as biomarker of progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab
cun id:
2406
VIROLOGIA
Immune response in SARS-CoV-2 infected children. One-year longitudinal study on seroprevalence, neutralizing antibodies, cellular immunity and oxidative stress in a cohort of children and adolescents infected with COVID-19.
Personalized Reusable Face Mask with Smart Nano-Assisted Destruction of Pathogens
Six-month follow-up in COVID-19 patients: CT analysis of pulmonary alteration
Organoidi: una nuova piattaforma per lo studio dell'interazione ospite-microrganismo
Protein-decorated lipid nanoparticles as SARS-Cov2 vaccine carriers.
Sviluppo di un protocollo per l'analisi della distribuzione delle mutazioni più frequenti del virus SARS-CoV-2 e sulla modalità di interazione tra la proteina Spike e anticorpi monoclonali neutralizzanti.
Risposta immunologica al vaccino SARS-CoV-2 in soggetti affetti da diabete mellito. Studio CoVaDiab (Sars-Cov2 Vaccine & Diabetes)
Redox-modulating compounds in the treatment of influenza virus and coronavirus infections.
THE ROLE OF MATRIX METALLOPROTEINASES AS A POTENTIAL DISEASE BIOMARKER IN PATIENTS WITH COVID-19